Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis
| dc.contributor.author | Solangon, Sarah Annie | |
| dc.contributor.author | Van Wely, Madelon | |
| dc.contributor.author | Van Mello, Norah | |
| dc.contributor.author | Mol, Ben W | |
| dc.contributor.author | Ross, Jackie A | |
| dc.contributor.author | Jurkovic, Davor | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2023-07-24T13:42:01Z | |
| dc.date.available | 2023-07-24T13:42:01Z | |
| dc.date.issued | 2023-09 | |
| dc.description | Funding Information: The NL study ran between April 2007 and January 2012 and included 73 women with conclusive ultrasound diagnosis of tubal EP with hCG <1500 IU/L or suspected tubal EP (PUL with plateauing serum hCG) <2000 IU/L. This was funded by a grant of the Netherlands Organization for Health Research and Development (ZonMw Clinical fellow grant 90700154). The UK study ran between August 2005 and June 2014 and included 80 women with conclusive ultrasound diagnosis of tubal EP and a serum hCG <1500 IU/L. This did not receive external funding. Baseline characteristics of intervention and comparison groups were similar and all prespecified outcomes were reported in both studies. Further characteristics of both studies are outlined in Table 1 . 9 11 | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 17 | |
| dc.format.extent | 2575715 | |
| dc.identifier | 267590582 | |
| dc.identifier | ccb881e6-2383-4000-bb9c-761287f2d59c | |
| dc.identifier | 37345445 | |
| dc.identifier | 85163202348 | |
| dc.identifier.citation | Solangon, S A, Van Wely, M, Van Mello, N, Mol, B W, Ross, J A & Jurkovic, D 2023, 'Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis', Acta Obstetricia et Gynecologica Scandinavica, vol. 102, no. 9, pp. 1159-1175. https://doi.org/10.1111/aogs.14617 | en |
| dc.identifier.doi | 10.1111/aogs.14617 | |
| dc.identifier.iss | 9 | en |
| dc.identifier.issn | 0001-6349 | |
| dc.identifier.other | unpaywall: 10.1111/aogs.14617 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21290 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85163202348&partnerID=8YFLogxK | en |
| dc.identifier.vol | 102 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Acta Obstetricia et Gynecologica Scandinavica | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | expectant management | en |
| dc.subject | medical treatment | en |
| dc.subject | methotrexate | en |
| dc.subject | pregnancy ectopic | en |
| dc.subject | pregnancy tubal | en |
| dc.subject | Pregnancy, Ectopic/drug therapy | en |
| dc.subject | Humans | en |
| dc.subject | Pregnancy, Tubal/drug therapy | en |
| dc.subject | Chorionic Gonadotropin | en |
| dc.subject | Pregnancy | en |
| dc.subject | Female | en |
| dc.subject | Watchful Waiting | en |
| dc.subject | Retrospective Studies | en |
| dc.subject | Abortifacient Agents, Nonsteroidal/therapeutic use | en |
| dc.subject | Methotrexate/therapeutic use | en |
| dc.subject | RG Gynecology and obstetrics | en |
| dc.subject | Obstetrics and Gynaecology | en |
| dc.subject.lcc | RG | en |
| dc.title | Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Solangon_Etal_AOGS_Methotrexate_Versus_Expectant_VOR.pdf
- Size:
- 2.46 MB
- Format:
- Adobe Portable Document Format
